Welcome to Lipidor AB

In Brief:
AKVANO® technology represents a completely new dosage form that creates a lipid layer on the skin surface for effective topical delivery of drugs and skin care treatment. AKVANO is designed for topical treatment, not systemic delivery.
The versatility of AKVANO technology enables the incorporation of structurally different active ingredients, including difficult molecules. More information>>
AKVANO formulations offer significant advantages over many currently available treatments, delivering benefits in key areas:
Lipid-based approach enables skin barrier reinforcement and many other possibilities for optimizing topical performance.
Effective delivery of active ingredients achieved through direct deposition of lipids on the skin, resulting in highly efficient physicochemical interaction with the skin barrier.
Non-touch functionality is an advantage in many product applications addressing irritated, injured and diseased skin. It also reduces the risk of contamination. Other advantages for the patient include ease of use, quick drying and non-greasiness.
Favourable product development conditions enabling efficient development and manufacturing of both originator and reformulated products.
Since it strengthens the lipid matrix of the outer layer of the skin (stratum corneum), AKVANO has many pharmaceutical and non-pharmaceutical product opportunities for topical treatment of damaged skin, ranging from wound and burn care, treatment of psoriasis and eczema, to treatment of mild conditions such as sunburn or dryness, and disinfection.
pix

Find out more…

NEWS: Newsletter April 26, 2017 >>

NEWS: Newsletter April 25, 2017 >>

NEWS:  Newsletter February 28, 2017 >>

NEWS: June  1, 2016 – Lipidor and Cadila Pharmaceuticals announce agreement on Phase III Clinical Study and joint commercialization of topical Psoriasis product.. More >

NEWS: June 1, 2016 – Novel spray product opportunities in skin care treatment, targeting dry, sensitive skin and injured skin  More >

 

BUSINESS OPPORTUNITIES: Read more